Rapport Therapeutics Insider Sale: A Planned Move, Not a Panic Sign
Insider sale of 8,500 RAPP shares by CSO Bredt David shows disciplined liquidity management, not panic—watch Phase 3 results for potential upside.
3 minutes to read
Rapport Therapeutics Inc